The Food & Drug Administration (FDA) is considering reversing its 2008 decision to allow physicians to treat advanced breast cancer patients with the drug Avasin due to its high cost about $8,000 monthly—about 17,500 Women are prescribed the drug annually, which has been shown to cut off the blood supply to tumors.
An FDA advisory panel has voted 12-1 to drop the endorsement for breast cancer treatment because of it’s “cost effectiveness” if approval of the drug is revoked, it will mark the beginning of Death Panels, by rationing prescription drugs.
More here from Telegraph UK
Related: Death by ObamaCare by Phillip Brennan Via Canada Free Press
Concerning Death Panels by Sarah Palin Via Facebook
